https://validator.w3.org/feed/docs/rss2.html Bladder, bowel and sexual problems Sensory symptoms Female sexual dysfunction in multiple sclerosis Sleep disorders Treatment strategy ECTRIMS Patient Community Day Abbreviations Mental ill-health in MS: prevalence and causes People with MS resources HCPs resources MS-Selfie InfoCards Intimate issues: bowel disorders Intimate issues Male sexual dysfunction in multiple sclerosis Natalizumab PML MS and bipolar disorder: understanding the link Natalizumab Development of MS-Selfie DMT InfoCards Management of mental health disorders in people with MS Switching-2-natalizumab Natalizumab – short summary Fatigue and insomnia Teriflunomide – short summary DMTs: details Fatigue in MS – a disabling symptom What type of MS do I have? Switching-2-teriflunomide S1P modulators Switching-2-S1P modulators S1P modulators – short summary ‘De-risking’ guide: monitoring requirements of individual DMTs Mitoxantrone – short summary What are the attributes of the specific DMTs? Intimate issues: bladder dysfunction Pelvic floor training Detecting and preventing urinary tract infections Sleep disrupted by pain and discomfort Understanding and managing insomnia in MS Symptomatic treatments Balance, movement and motor symptoms Teriflunomide Hidden or delayed problems Symptoms and diagnosis What impact does MS have on pregnancy and having children? Off-label disease-modifying therapies Do I understand the concepts of treat-2-target and NEDA? Medical gaslighting – what is it, and how to avoid it? How can I reduce my chances of adverse events on specific DMTs? Do I have active MS? About MS-Selfie